Presbia PLC (NASDAQ:LENS) – Equities researchers at Jefferies Group dropped their FY2019 EPS estimates for shares of Presbia PLC in a research note issued on Monday. Jefferies Group analyst R. Denhoy now forecasts that the brokerage will post earnings per share of $0.13 for the year, down from their prior estimate of $0.14. Jefferies Group has a “Market Outperform” rating on the stock. Jefferies Group also issued estimates for Presbia PLC’s FY2020 earnings at $1.05 EPS.
LENS has been the subject of a number of other research reports. TheStreet cut Presbia PLC from a “hold” rating to a “sell” rating in a report on Thursday, September 1st. Zacks Investment Research raised Presbia PLC from a “hold” rating to a “buy” rating and set a $5.50 price target for the company in a report on Tuesday, June 28th. Finally, Rodman & Renshaw set a $14.00 price target on Presbia PLC and gave the stock a “buy” rating in a report on Thursday, July 21st.
Presbia PLC (NASDAQ:LENS) traded down 3.55% during trading on Wednesday, reaching $4.35. The company had a trading volume of 1,703 shares. Presbia PLC has a 52 week low of $2.94 and a 52 week high of $6.89. The firm’s market capitalization is $58.02 million. The company’s 50-day moving average is $4.40 and its 200 day moving average is $4.53.
About Presbia PLC
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States.
Receive News & Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related companies with MarketBeat.com's FREE daily email newsletter.